Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

FDA panel to review first heart failure device of its kind

The shunt device being reviewed showed a 52% reduction in hospitalizations and favorable trends in mortality in patients with heart failure with reduced ejection fraction. 

money dollar benjamin cash finance graph chart deal dollar

Medicare MRI reimbursement has plummeted 77% since 2003, when adjusting for inflation

Exams are being delivered faster, thanks to abbreviated protocols, but experts contend insurers should not cut MRI pay because of such efficiencies. 

Optum UnitedHealthcare UnitedHealth Group HQ

UnitedHealthcare reimburses its Optum providers at a 17% premium, study finds

The findings are from research conducted by the Commonwealth Fund that looked at nationwide provider reimbursement data. While the sample size is small, it shows the insurer tends to favor its own doctors.

Statue of Liberty New York City healthcare

Judge protects New York ‘shield’ rule against Texas abortion lawsuit

A federal judge dismissed a lawsuit from Texas Attorney General Ken Paxton, who sought an injunction against abortion medications being shipped to women in his state.

Thumbnail

Experts caution patients on the dangers of boutique fetal ultrasounds

Due to the elective, rather than diagnostic, nature of these exams, operators are not required to complete formal training or be registered if the scans are done in privately owned entities. 

startup business healthcare medtech heart

Medtech startup co-founded by cardiologist seeks FDA clearance for new-look perfusion device

Tulyp Medical, a French medtech startup, has emerged from stealth focused on securing FDA clearance for a patented perfusion device.

Dexcom is recalling a specific version of the Android smartphone app associated with its G6 Continuous Glucose Monitoring (CGM) System.

FDA highlights new Class I recall for Dexcom CGM app

Dexcom recalled its G6 smartphone app after a software error was causing it to stop working with no warning. This is a Class I recall, which means failing to follow the company's instructions could result in a serious adverse event.

Drugs money scam

5 healthcare industry giants funnel over $333M in research payments to radiologists

Merck was the No. 1 funder for radiologists, contributing nearly $108 million in payments, followed by imaging manufacturer Siemens Healthineers ($64 million) and drugmaker Novartis ($57 million).